Invictus MD Selected Top 25 Long Term Stock Buys by CANNAINVESTOR Magazine

Posted on Categories: Investor Relations

Vancouver, BC, November 25, 2016 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce they will be listed as one of the top 25 long-term stock buys within the cannabis industry according to CANNAINVESTOR Magazine. Invictus MD and Future Harvest will be featured as the cover story within the magazine, set to be released on January 23, 2017.

“We chose to feature Invictus in our January / February 2017 magazine issue and list them as one of the best long-term stock buys due to their growth, vision, leadership and ancillary nature. Many investors aren’t quite ready to invest in industry companies that ‘touch the plant,’ so Invictus and more specifically Future Harvest provides an opportunity for investors to participate in the early growth stage of the cannabis industry with minimal risk. Chris Pearson and his team at Future Harvest are on track to be one of the fastest growing hydroponic manufacturing companies within the cannabis industry,” stated D. A. Wallace, Founder and Senior Editor of CANNAINVESTOR Magazine.

Read more “Invictus MD Selected Top 25 Long Term Stock Buys by CANNAINVESTOR Magazine”

Invictus MD announces increase in private placement to up to $12,000,000

Posted on Categories: Investor Relations

Vancouver, BC, November 24th, 2016 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce that due to robust demand, the Company is increasing the size of its private placement of units announced earlier today to up to CAD$12,000,000. For further details on the private placement and the concurrent acquisitions of AB Labs and AB Farms, please refer to the Company’s earlier press release.

Read more “Invictus MD announces increase in private placement to up to $12,000,000”

Invictus MD announces binding LOI to acquire Health Canada Licensed Producer under the ACMPR and concurrent $10,000,000 private placement

Posted on Categories: Investor Relations

Vancouver, BC, November 24th, 2016 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce that it has entered into a binding letter of intent to acquire 33 1/3% of AB Laboratories Inc. (“AB Labs”), a Licensed Producer under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”), and 33 1/3% of AB Farms Inc. (“AB Farms”), which has a proposed secondary expansion facility (totaling approximately 100 acres) currently in planning for a total aggregate transaction value of $17,250,000 based on Invictus MD’s November 17th closing price.

Read more “Invictus MD announces binding LOI to acquire Health Canada Licensed Producer under the ACMPR and concurrent $10,000,000 private placement”

Dr. Paul Shipley of University of British Columbia to Join Future Harvest Development as Research and Development Consultant

Posted on Categories: Investor Relations

Vancouver, BC, November 22, 2016 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) has successfully retained the services of Dr. Paul Shipley of the University of British Columbia (“UBC”) for the role of Research and Development Consultant for the Future Harvest Development (“FHD”) Product Development and Special Projects department.

The Company anticipates Dr. Shipley’s expertise and involvement will contribute to the formation of leading-edge agricultural growth supplements that improve cannabis plants’ health and yields while rebuilding surrounding soil structures, in accordance with FHD’s dedication to creating industry-leading products that offer long-term sustainability.

Read more “Dr. Paul Shipley of University of British Columbia to Join Future Harvest Development as Research and Development Consultant”